Screener / SEC EDGAR /CIK 0000818686 /10-K filed Feb 3, 2026, compared with Feb 5, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Teva Pharmaceutical Industries Ltd TEVA

Compare with peers Embed

TEVA among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+4.3%118th of 155 · median +10.5%
Net margin
-4.1%15.3%
2.9%92nd of 154 · median 6.8%
Return on equity
-5.2%18.5%
6.3%85th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
7.2%88th of 145 · median 10.0%
Debt / equity (less is better)
1.160.42
2.1098th of 108 · median 0.69

TEVA and 9 peers, year by year

The 9 Health care companies closest to TEVA in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
TEVA Teva Pharmaceutical Industries Ltd FY2025 $17.3B+4.3%51.8%12.5%8.2%6.7%17.8%2.12
IQV IQVIA FY2025 $16.3B+5.9%-13.4%8.3%12.6%20.9%2.42
REGN Regeneron Pharmaceuticals FY2025 $14.3B+1.0%-24.9%31.4%28.4%14.4%0.06
UHS Universal Health Services FY2025 $17.4B+9.7%-11.5%8.6%4.9%20.5%0.66
BTSG BrightSpring Health Services, Inc. FY2025 $12.9B+28.2%11.8%2.3%1.5%3.1%10.2%1.34
VTRS Viatris FY2025 $14.3B−3.0%35.1%−18.6%−24.6%13.5%−23.9%0.98
LH Labcorp FY2025 $14.0B+7.2%28.8%9.9%6.3%8.6%10.2%0.65
DVA DaVita FY2025 $13.6B+6.5%-15.0%5.5%9.6%n/mn/m
HSIC Henry Schein FY2025 $13.2B+4.0%31.1%5.0%3.0%4.3%12.3%0.96
BSX Boston Scientific FY2025 $20.1B+19.9%69.0%18.0%14.4%18.2%12.0%0.47

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

TEVATeva Pharmaceutical Industries Ltd
FY2016 revenue $21.9BFY2017 revenue $22.4BFY2018 revenue $18.3BFY2019 revenue $16.9BFY2020 revenue $16.7BFY2021 revenue $15.9BFY2022 revenue $14.9BFY2023 revenue $15.8BFY2024 revenue $16.5BFY2025 revenue $17.3B FY2016 net margin 1.5%FY2017 net margin −72.7%FY2018 net margin −11.8%FY2019 net margin −5.9%FY2020 net margin −24.0%FY2021 net margin 2.6%FY2022 net margin −16.4%FY2023 net margin −3.5%FY2024 net margin −9.9%FY2025 net margin 8.2% FY2016FY2025
Revenue$17.3B Growth+4.3% Net margin8.2%
IQVIQVIA
FY2016 revenue $6.9BFY2017 revenue $9.7BFY2018 revenue $10.4BFY2019 revenue $11.1BFY2020 revenue $11.4BFY2021 revenue $13.9BFY2022 revenue $14.4BFY2023 revenue $15.0BFY2024 revenue $15.4BFY2025 revenue $16.3B FY2016 net margin 1.0%FY2017 net margin 13.1%FY2018 net margin 2.5%FY2019 net margin 1.7%FY2020 net margin 2.5%FY2021 net margin 7.0%FY2022 net margin 7.6%FY2023 net margin 9.1%FY2024 net margin 8.9%FY2025 net margin 8.3% FY2016FY2025
Revenue$16.3B Growth+5.9% Net margin8.3%
REGNRegeneron Pharmaceuticals
FY2016 revenue $4.9BFY2017 revenue $5.9BFY2018 revenue $5.1BFY2019 revenue $6.6BFY2020 revenue $8.5BFY2021 revenue $16.1BFY2022 revenue $12.2BFY2023 revenue $13.1BFY2024 revenue $14.2BFY2025 revenue $14.3B FY2016 net margin 18.4%FY2017 net margin 20.4%FY2018 net margin 47.5%FY2019 net margin 32.3%FY2020 net margin 41.3%FY2021 net margin 50.2%FY2022 net margin 35.6%FY2023 net margin 30.1%FY2024 net margin 31.1%FY2025 net margin 31.4% FY2016FY2025
Revenue$14.3B Growth+1.0% Net margin31.4%
UHSUniversal Health Services
FY2016 revenue $9.8BFY2017 revenue $10.4BFY2018 revenue $10.8BFY2019 revenue $11.4BFY2020 revenue $11.6BFY2021 revenue $12.6BFY2022 revenue $13.4BFY2023 revenue $14.3BFY2024 revenue $15.8BFY2025 revenue $17.4B FY2016 net margin 7.2%FY2017 net margin 7.2%FY2018 net margin 7.2%FY2019 net margin 7.2%FY2020 net margin 8.2%FY2021 net margin 7.8%FY2022 net margin 5.0%FY2023 net margin 5.0%FY2024 net margin 7.2%FY2025 net margin 8.6% FY2016FY2025
Revenue$17.4B Growth+9.7% Net margin8.6%
BTSGBrightSpring Health Services, Inc.
FY2022 revenue $7.7BFY2023 revenue $7.7BFY2024 revenue $10.1BFY2025 revenue $12.9B FY2022 net margin −0.7%FY2023 net margin −2.0%FY2024 net margin −0.2%FY2025 net margin 1.5% FY2016FY2025
Revenue$12.9B Growth+28.2% Net margin1.5%
VTRSViatris
FY2018 revenue $11.4BFY2019 revenue $11.5BFY2020 revenue $11.9BFY2021 revenue $17.9BFY2022 revenue $16.3BFY2023 revenue $15.4BFY2024 revenue $14.7BFY2025 revenue $14.3B FY2018 net margin 3.1%FY2019 net margin 0.1%FY2020 net margin −5.6%FY2021 net margin −7.1%FY2022 net margin 12.8%FY2023 net margin 0.4%FY2024 net margin −4.3%FY2025 net margin −24.6% FY2016FY2025
Revenue$14.3B Growth−3.0% Net margin−24.6%
LHLabcorp
FY2016 revenue $9.6BFY2017 revenue $10.3BFY2018 revenue $11.3BFY2019 revenue $11.6BFY2020 revenue $14.0BFY2021 revenue $13.1BFY2022 revenue $11.9BFY2023 revenue $12.2BFY2024 revenue $13.0BFY2025 revenue $14.0B FY2016 net margin 7.5%FY2017 net margin 11.9%FY2018 net margin 7.8%FY2019 net margin 7.1%FY2020 net margin 11.1%FY2021 net margin 18.1%FY2022 net margin 10.8%FY2023 net margin 3.4%FY2024 net margin 5.7%FY2025 net margin 6.3% FY2016FY2025
Revenue$14.0B Growth+7.2% Net margin6.3%
DVADaVita
FY2016 revenue $10.7BFY2017 revenue $10.9BFY2018 revenue $11.4BFY2019 revenue $11.4BFY2020 revenue $11.6BFY2021 revenue $11.6BFY2022 revenue $11.6BFY2023 revenue $12.1BFY2024 revenue $12.8BFY2025 revenue $13.6B FY2016 net margin 8.2%FY2017 net margin 6.1%FY2018 net margin 1.4%FY2019 net margin 7.1%FY2020 net margin 6.7%FY2021 net margin 8.4%FY2022 net margin 4.8%FY2023 net margin 5.7%FY2024 net margin 7.3%FY2025 net margin 5.5% FY2016FY2025
Revenue$13.6B Growth+6.5% Net margin5.5%
HSICHenry Schein
FY2016 revenue $11.6BFY2017 revenue $8.9BFY2018 revenue $9.4BFY2019 revenue $10.0BFY2020 revenue $10.1BFY2021 revenue $12.4BFY2022 revenue $12.6BFY2023 revenue $12.3BFY2024 revenue $12.7BFY2025 revenue $13.2B FY2016 net margin 4.4%FY2017 net margin 4.6%FY2018 net margin 5.7%FY2019 net margin 7.0%FY2020 net margin 4.0%FY2021 net margin 5.1%FY2022 net margin 4.3%FY2023 net margin 3.4%FY2024 net margin 3.1%FY2025 net margin 3.0% FY2016FY2025
Revenue$13.2B Growth+4.0% Net margin3.0%
BSXBoston Scientific
FY2016 revenue $9.1BFY2017 revenue $9.0BFY2018 revenue $9.8BFY2019 revenue $10.7BFY2020 revenue $9.9BFY2021 revenue $11.9BFY2022 revenue $12.7BFY2023 revenue $14.2BFY2024 revenue $16.7BFY2025 revenue $20.1B FY2016 net margin 3.8%FY2017 net margin 1.1%FY2018 net margin 17.0%FY2019 net margin 43.8%FY2020 net margin −1.2%FY2021 net margin 8.3%FY2022 net margin 5.1%FY2023 net margin 11.0%FY2024 net margin 11.1%FY2025 net margin 14.4% FY2016FY2025
Revenue$20.1B Growth+19.9% Net margin14.4%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 200 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: $6.9B, $9.7B, $10.4B, $11.1B, $11.4B, $13.9B, $14.4B, $15.0B, $15.4B, $16.3B IQV REGN: $4.9B, $5.9B, $5.1B, $6.6B, $8.5B, $16.1B, $12.2B, $13.1B, $14.2B, $14.3B REGN UHS: $9.8B, $10.4B, $10.8B, $11.4B, $11.6B, $12.6B, $13.4B, $14.3B, $15.8B, $17.4B UHS BTSG: -, -, -, -, -, -, $7.7B, $7.7B, $10.1B, $12.9B BTSG VTRS: -, -, $11.4B, $11.5B, $11.9B, $17.9B, $16.3B, $15.4B, $14.7B, $14.3B VTRS LH: $9.6B, $10.3B, $11.3B, $11.6B, $14.0B, $13.1B, $11.9B, $12.2B, $13.0B, $14.0B LH DVA: $10.7B, $10.9B, $11.4B, $11.4B, $11.6B, $11.6B, $11.6B, $12.1B, $12.8B, $13.6B DVA HSIC: $11.6B, $8.9B, $9.4B, $10.0B, $10.1B, $12.4B, $12.6B, $12.3B, $12.7B, $13.2B HSIC BSX: $9.1B, $9.0B, $9.8B, $10.7B, $9.9B, $11.9B, $12.7B, $14.2B, $16.7B, $20.1B BSX TEVA: $21.9B, $22.4B, $18.3B, $16.9B, $16.7B, $15.9B, $14.9B, $15.8B, $16.5B, $17.3B TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here. REGN, BTSG, LH: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−24.3% +89.1% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: +19.9%, +42.4%, +7.3%, +6.5%, +2.4%, +22.1%, +3.9%, +4.0%, +2.8%, +5.9% IQV REGN: +18.4%, +20.8%, +14.3%, +27.4%, +29.6%, +89.1%, −24.3%, +7.8%, +8.3%, +1.0% REGN UHS: +8.0%, +6.6%, +3.5%, +5.6%, +1.6%, +9.4%, +6.0%, +6.6%, +10.8%, +9.7% UHS BTSG: -, -, -, -, -, -, -, +14.3%, +31.0%, +28.2% BTSG VTRS: -, -, -, +0.9%, +4.0%, +50.7%, −9.0%, −5.1%, −4.5%, −3.0% VTRS LH: +11.1%, +7.9%, +9.9%, +2.0%, +21.0%, +15.3%, −9.7%, +2.5%, +7.0%, +7.2% LH DVA: +7.3%, +1.6%, +4.9%, −0.1%, +1.4%, +0.6%, −0.1%, +4.6%, +5.6%, +6.5% DVA HSIC: +8.9%, +7.7%, +6.0%, +6.0%, +1.3%, +22.6%, +2.0%, −2.4%, +2.7%, +4.0% HSIC BSX: +12.2%, +7.9%, +8.6%, +9.3%, −7.7%, +19.9%, +6.7%, +12.3%, +17.6%, +19.9% BSX TEVA: +11.5%, +2.2%, −16.4%, −7.6%, −1.4%, −4.7%, −6.0%, +6.2%, +4.4%, +4.3% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −24.3% to +89.1%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

11.8% 71.4% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BTSG: -, -, -, -, -, -, 17.5%, 14.8%, 12.6%, 11.8% BTSG VTRS: -, -, 35.0%, 33.9%, 31.8%, 31.2%, 40.0%, 41.7%, 38.2%, 35.1% VTRS LH: 29.9%, 30.0%, 28.0%, 28.1%, 35.4%, 38.0%, 31.3%, 27.7%, 27.9%, 28.8% LH HSIC: 27.9%, 30.9%, 30.9%, 31.0%, 27.8%, 29.6%, 30.3%, 31.3%, 31.7%, 31.1% HSIC BSX: 65.7%, 71.3%, 71.4%, 71.0%, 65.0%, 68.8%, 68.8%, 69.5%, 68.6%, 69.0% BSX TEVA: 53.2%, 47.4%, 45.4%, 44.6%, 46.4%, 47.8%, 46.7%, 48.2%, 48.7%, 51.8% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 11.8% to 71.4%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
TEVA Dec 53.2%47.4%45.4%44.6%46.4%47.8%46.7%48.2%48.7%51.8%
IQV Dec ----------
REGN Dec ----------
UHS Dec ----------
BTSG Dec ------17.5%14.8%12.6%11.8%
VTRS Dec --35.0%33.9%31.8%31.2%40.0%41.7%38.2%35.1%
LH Dec 29.9%30.0%28.0%28.1%35.4%38.0%31.3%27.7%27.9%28.8%
DVA Dec ----------
HSIC Dec 27.9%30.9%30.9%31.0%27.8%29.6%30.3%31.3%31.7%31.1%
BSX Dec 65.7%71.3%71.4%71.0%65.0%68.8%68.8%69.5%68.6%69.0%
Peer median29.9%30.9%33.0%32.4%33.6%34.6%31.3%31.3%31.7%31.1%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−78.1% 55.7% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: 8.4%, 6.8%, 7.1%, 7.0%, 6.4%, 10.0%, 12.5%, 13.2%, 14.3%, 13.4% IQV REGN: 27.4%, 35.4%, 49.3%, 33.7%, 42.1%, 55.7%, 38.9%, 30.9%, 28.1%, 24.9% REGN UHS: 13.1%, 12.3%, 10.9%, 10.7%, 11.8%, 10.8%, 7.5%, 8.2%, 10.6%, 11.5% UHS BTSG: -, -, -, -, -, -, 2.4%, 0.8%, 1.1%, 2.3% BTSG VTRS: -, -, 7.9%, 6.2%, −1.8%, −0.2%, 9.9%, 5.0%, 0.1%, −18.6% VTRS LH: 13.3%, 12.7%, 11.7%, 11.5%, 17.5%, 23.2%, 12.1%, 6.0%, 8.4%, 9.9% LH DVA: 19.0%, 16.7%, 13.4%, 14.4%, 14.7%, 15.5%, 11.5%, 13.2%, 16.3%, 15.0% DVA HSIC: 6.7%, 7.5%, 6.4%, 7.2%, 5.3%, 6.9%, 5.9%, 5.0%, 4.9%, 5.0% HSIC BSX: 4.9%, 14.2%, 15.3%, 14.1%, −0.8%, 10.1%, 13.0%, 16.5%, 15.5%, 18.0% BSX TEVA: 9.8%, −78.1%, −9.0%, −2.6%, −21.4%, 10.8%, −14.7%, 2.7%, −1.8%, 12.5% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −78.1% to 55.7%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−72.7% 50.2% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: 1.0%, 13.1%, 2.5%, 1.7%, 2.5%, 7.0%, 7.6%, 9.1%, 8.9%, 8.3% IQV REGN: 18.4%, 20.4%, 47.5%, 32.3%, 41.3%, 50.2%, 35.6%, 30.1%, 31.1%, 31.4% REGN UHS: 7.2%, 7.2%, 7.2%, 7.2%, 8.2%, 7.8%, 5.0%, 5.0%, 7.2%, 8.6% UHS BTSG: -, -, -, -, -, -, −0.7%, −2.0%, −0.2%, 1.5% BTSG VTRS: -, -, 3.1%, 0.1%, −5.6%, −7.1%, 12.8%, 0.4%, −4.3%, −24.6% VTRS LH: 7.5%, 11.9%, 7.8%, 7.1%, 11.1%, 18.1%, 10.8%, 3.4%, 5.7%, 6.3% LH DVA: 8.2%, 6.1%, 1.4%, 7.1%, 6.7%, 8.4%, 4.8%, 5.7%, 7.3%, 5.5% DVA HSIC: 4.4%, 4.6%, 5.7%, 7.0%, 4.0%, 5.1%, 4.3%, 3.4%, 3.1%, 3.0% HSIC BSX: 3.8%, 1.1%, 17.0%, 43.8%, −1.2%, 8.3%, 5.1%, 11.0%, 11.1%, 14.4% BSX TEVA: 1.5%, −72.7%, −11.8%, −5.9%, −24.0%, 2.6%, −16.4%, −3.5%, −9.9%, 8.2% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −72.7% to 50.2%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$74.8M $6.5B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: $696.0M, $601.0M, $795.0M, $835.0M, $1.3B, $2.3B, $1.6B, $1.5B, $2.1B, $2.1B IQV REGN: $974.0M, $1.0B, $1.8B, $2.0B, $2.0B, $6.5B, $4.4B, $3.9B, $3.7B, $4.1B REGN UHS: $813.9M, $690.1M, $609.8M, $804.4M, $1.6B, $28.0M, $262.0M, $524.7M, $1.1B, $849.2M UHS BTSG: -, -, -, -, -, -, −$74.8M, $137.3M, −$57.1M, $394.7M BTSG VTRS: -, -, $2.1B, $1.6B, $988.8M, $2.6B, $2.6B, $2.5B, $2.0B, $1.9B VTRS LH: $918.2M, $1.2B, $925.6M, $1.0B, $1.8B, $2.7B, $1.5B, $874.1M, $1.1B, $1.2B LH DVA: $1.1B, $1.0B, $784.5M, $1.3B, $1.3B, $1.3B, $961.1M, $1.5B, $1.5B, $1.3B DVA HSIC: $572.4M, $483.1M, $613.4M, $577.9M, $550.0M, $631.0M, $506.0M, $353.0M, $700.0M, $573.0M HSIC BSX: $806.0M, $1.1B, −$6.0M, $1.4B, $1.1B, $1.3B, $938.0M, $1.8B, $2.6B, $3.7B BSX TEVA: $3.0B, $1.4B, $1.8B, $223.0M, $638.0M, $236.0M, $1.0B, $842.0M, $749.0M, $1.1B TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$74.8M to $6.5B. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−1.0% 40.6% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: 10.1%, 6.2%, 7.6%, 7.5%, 11.8%, 16.6%, 11.0%, 10.0%, 13.7%, 12.6% IQV REGN: 20.0%, 17.6%, 35.2%, 30.5%, 23.6%, 40.6%, 36.3%, 29.5%, 25.8%, 28.4% REGN UHS: 8.3%, 6.6%, 5.7%, 7.1%, 14.1%, 0.2%, 2.0%, 3.7%, 7.1%, 4.9% UHS BTSG: -, -, -, -, -, -, −1.0%, 1.8%, −0.6%, 3.1% BTSG VTRS: -, -, 18.3%, 13.8%, 8.3%, 14.3%, 15.9%, 16.4%, 13.4%, 13.5% VTRS LH: 9.6%, 11.5%, 8.2%, 9.0%, 12.5%, 20.5%, 12.9%, 7.2%, 8.4%, 8.6% LH DVA: 10.7%, 9.3%, 6.9%, 11.5%, 11.3%, 11.1%, 8.3%, 12.3%, 11.4%, 9.6% DVA HSIC: 4.9%, 5.4%, 6.5%, 5.8%, 5.4%, 5.1%, 4.0%, 2.9%, 5.5%, 4.3% HSIC BSX: 8.9%, 12.2%, −0.1%, 12.8%, 11.4%, 11.1%, 7.4%, 12.6%, 15.8%, 18.2% BSX TEVA: 13.6%, 6.0%, 9.8%, 1.3%, 3.8%, 1.5%, 7.0%, 5.3%, 4.5%, 6.7% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −1.0% to 40.6%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−93.7% 129.5% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: 0.8%, 16.0%, 3.9%, 3.2%, 4.6%, 16.0%, 18.9%, 22.2%, 22.6%, 20.9% IQV REGN: 20.1%, 19.5%, 27.9%, 19.1%, 31.9%, 43.0%, 19.1%, 15.2%, 15.0%, 14.4% REGN UHS: 15.5%, 15.1%, 14.5%, 14.8%, 14.9%, 16.3%, 11.4%, 11.7%, 17.1%, 20.5% UHS BTSG: -, -, -, -, -, -, −7.1%, −26.4%, −1.1%, 10.2% BTSG VTRS: -, -, 2.9%, n/m, −2.9%, −6.2%, 9.9%, 0.3%, −3.4%, −23.9% VTRS LH: 12.9%, 18.0%, 12.5%, 10.8%, 16.5%, 23.1%, 12.7%, 5.3%, 9.3%, 10.2% LH DVA: 18.9%, 14.1%, 4.3%, 38.0%, 55.9%, 129.5%, 78.7%, 65.5%, n/m, n/m DVA HSIC: 18.1%, 14.5%, 18.1%, 23.2%, 12.1%, 18.4%, 15.6%, 11.4%, 11.5%, 12.3% HSIC BSX: 5.2%, 1.5%, 19.1%, 33.9%, −0.8%, 5.9%, 3.7%, 8.1%, 8.5%, 12.0% BSX TEVA: 1.0%, −93.7%, −14.6%, −7.2%, −39.8%, 4.1%, −31.3%, −7.4%, −30.5%, 17.8% TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −93.7% to 129.5%. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 12.53 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: 0.84, 1.28, 1.64, 1.94, 2.09, 2.01, 2.21, 2.24, 2.30, 2.42 IQV REGN: -, -, -, 0.00, 0.18, 0.11, 0.09, 0.08, 0.07, 0.06 REGN UHS: 0.91, 0.81, 0.74, 0.72, 0.61, 0.69, 0.81, 0.80, 0.68, 0.66 UHS BTSG: -, -, -, -, -, -, -, 5.75, 1.58, 1.34 BTSG VTRS: -, -, -, n/m, 1.13, 1.13, 0.91, 0.89, 0.75, 0.98 VTRS LH: 1.05, 0.99, 0.85, 0.87, 0.61, 0.53, 0.53, 0.64, 0.79, 0.65 LH DVA: 1.96, 1.99, 2.73, 3.80, 5.84, 11.79, 12.53, 7.95, n/m, n/m DVA HSIC: 0.28, 0.33, 0.66, 0.25, 0.21, 0.25, 0.33, 0.64, 0.75, 0.96 HSIC BSX: 0.80, 0.80, 0.81, 0.72, 0.60, 0.55, 0.51, 0.47, 0.49, 0.47 BSX TEVA: 0.98, 1.66, 1.97, 1.93, 2.59, 2.24, 2.72, 2.64, 3.31, 2.12 TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 12.53. A gap is a year with no number. A ring marks where a line starts: REGN, BTSG, VTRS have no earlier 10-K here.

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$16.26 $71.97 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 IQV: $0.47, $5.74, $1.24, $0.96, $1.43, $4.95, $5.72, $7.29, $7.49, $7.84 IQV REGN: $7.70, $10.34, $21.29, $18.46, $30.52, $71.97, $38.22, $34.77, $38.34, $41.48 REGN UHS: $7.14, $7.81, $8.31, $9.13, $10.99, $11.82, $9.14, $10.23, $16.82, $23.10 UHS BTSG: -, -, -, -, -, -, −$0.46, −$1.31, −$0.09, $0.87 BTSG VTRS: -, -, $0.68, $0.03, −$1.11, −$1.05, $1.71, $0.05, −$0.53, −$3.00 VTRS LH: $6.82, $11.81, $8.61, $8.35, $15.88, $24.39, $13.97, $4.77, $8.84, $10.46 LH DVA: $4.29, $3.47, $0.92, $5.27, $6.31, $8.90, $5.85, $7.42, $10.73, $9.84 DVA HSIC: $3.10, $2.57, $3.49, $4.65, $2.82, $4.45, $3.91, $3.16, $3.05, $3.27 HSIC BSX: $0.25, $0.08, $1.19, $3.33, −$0.08, $0.69, $0.45, $1.07, $1.25, $1.94 BSX TEVA: $0.07, −$16.26, −$2.35, −$0.91, −$3.64, $0.38, −$2.20, −$0.50, −$1.45, $1.21 TEVA
TEVA is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$16.26 to $71.97. A gap is a year with no number. A ring marks where a line starts: BTSG, VTRS have no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out TEVA and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: TEVA's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.